BE708780A - - Google Patents

Info

Publication number
BE708780A
BE708780A BE708780DA BE708780A BE 708780 A BE708780 A BE 708780A BE 708780D A BE708780D A BE 708780DA BE 708780 A BE708780 A BE 708780A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE708780A publication Critical patent/BE708780A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE708780D 1966-12-29 1967-12-29 BE708780A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60555066A 1966-12-29 1966-12-29
US84156169A 1969-07-14 1969-07-14

Publications (1)

Publication Number Publication Date
BE708780A true BE708780A (fr) 1968-07-01

Family

ID=27084980

Family Applications (1)

Application Number Title Priority Date Filing Date
BE708780D BE708780A (fr) 1966-12-29 1967-12-29

Country Status (6)

Country Link
US (1) US3547999A (fr)
BE (1) BE708780A (fr)
DE (1) DE1643310A1 (fr)
FR (1) FR7819M (fr)
GB (1) GB1147379A (fr)
NL (1) NL6717807A (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946119A (en) * 1974-12-23 1976-03-23 Sandoz, Inc. Optionally substituted α-tertiary butyl-p-phenoxybenzylamines and their use as hypolipidemic agents
US4034113A (en) * 1975-04-09 1977-07-05 Shulgin Alexander T Treatment of senile geriatric patients to restore performance
US4704407A (en) * 1984-12-20 1987-11-03 Eli Lilly And Company Soluble dobutamine salts
CN1826322B (zh) * 2003-07-22 2012-04-18 艾尼纳制药公司 用于预防和治疗相关病症而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物
US7022492B2 (en) * 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US6991911B2 (en) * 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US20050130243A1 (en) * 2003-12-15 2005-06-16 Zheng Yi F. Assay for entactogens
US7037669B2 (en) * 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US7115383B2 (en) * 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
CA2559038C (fr) 2004-03-23 2013-09-10 Arena Pharmaceuticals, Inc. Methodes de preparation de n-aryl-n'-[3-(1h-pyrazol-5-yl) phenylurees] substituees et leurs intermediaires
US8877802B2 (en) * 2005-07-28 2014-11-04 Duke Univerity Antiparkinsonian action of phenylisopropylamines
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
US9567327B2 (en) 2007-08-15 2017-02-14 Arena Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (fr) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Procédés utiles pour la préparation de 1-[3-(4-bromo-2-méthyl-2h-pyrazol-3-yl)-4-méthoxy-phényl]-3-(2,4-difluoro‑phényl)-urée, et formes cristallines associées
EP2364142B1 (fr) 2008-10-28 2018-01-17 Arena Pharmaceuticals, Inc. Compositions de modulateurs du récepteur de la sérotonine 5-ht2a utiles pour le traitement des troubles associés audit récepteur
AU2016276966A1 (en) 2015-06-12 2018-01-18 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of REM sleep behavior disorder
TW201720439A (zh) 2015-07-15 2017-06-16 Axovant Sciences Gmbh 用於預防及治療與神經退化性疾病相關的幻覺之作為５－ｈｔ２ａ血清素受體的二芳基及芳基雜芳基脲衍生物

Also Published As

Publication number Publication date
FR7819M (fr) 1970-05-20
NL6717807A (fr) 1968-07-01
US3547999A (en) 1970-12-15
GB1147379A (en) 1969-04-02
DE1643310A1 (de) 1971-06-03

Similar Documents

Publication Publication Date Title
FR7819M (fr)
AT281852B (fr)
AU1141566A (fr)
AU1534566A (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU414526B2 (fr)
AU218666A (fr)
AU1111066A (fr)
AU1144366A (fr)
AU1393566A (fr)
BE692384A (fr)
BE675139A (fr)
BE694314A (fr)
BE694303A (fr)
BE694007A (fr)
BE693878A (fr)
BE694725A (fr)
AU2390066A (fr)
AU407778B2 (fr)
BE693810A (fr)
AU411645B2 (fr)
BE693063A (fr)
BE529218A (fr)
BE692140A (fr)